| Symbol |
Name |
|
AGO2
|
argonaute RISC catalytic component 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
E2F1
|
E2F transcription factor 1
|
|
ESR1
|
estrogen receptor 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
HLX
|
H2.0-like homeobox
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
LIMD1
|
LIM domains containing 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR106A
|
microRNA 106a
|
|
MIR215
|
microRNA 215
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
PER2
|
period circadian clock 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R26P1
|
protein phosphatase 1, regulatory subunit 26 pseudogene 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
TBX2
|
T-box 2
|
|
TP53
|
tumor protein p53
|
